title: Dried blood spot analysis: an easy and reliable tool to monitor the biochemical effect of hematopoietic stem cell transplantation in hurler syndrome patients.
abstract: Hurler syndrome (HS), the most severe phenotype in the spectrum of mucopolysaccharidosis type I, is caused by a deficiency of the lysosomal enzyme alpha-L-iduronidase (IDUA). At present, hematopoietic stem cell transplantation (HSCT) is the only treatment able to prevent disease progression in the central nervous system, and therefore considered the treatment of choice in HS patients. Because IDUA enzyme activities after HSCT have been suggested to influence the prognosis of HS patients, monitoring these activities after HSCT remains highly important. The use of dried blood spots (DBS) for enzyme analysis can be a useful alternative to the conventional leukocyte assay. Importantly, this method allows for convenient worldwide shipment, and can therefore be applied to monitor patients from larger areas of the world, or during large-scale international studies. Furthermore, this method requires only a minimal amount of blood. From 13 HS patients receiving HSCT, 36 paired whole blood and DBS samples were analyzed to assess leukocyte and DBS IDUA activities, respectively. To correct for potential interfering factors, simultaneous assay of the alpha-Galactosidase-A (AGA) activity was performed in the DBS samples and an IDUA/AGA ratio was calculated. A strong linear correlation was demonstrated between the DBS IDUA/AGA ratio and the leukocyte IDUA activity (r(2) = .875, P < .001). This correlation was applicable to all enzyme activities, including the activities measured early after HSCT as well as heterozygous activities because of mixed chimerism or the use of a carrier donor. These results demonstrate that the DBS method is reliable to monitor the biochemical effect of HSCT in HS patients.
authors.affiliation: Department of Hematology, Immunology and Stem Cell Transplantation University Medical Center, Utrecht, The Netherlands. m.aldenhoven@umcutrecht.nl
authors.forename: Mieke
authors.initials: M
authors.lastname: Aldenhoven
authors.forename: Tom J
authors.initials: TJ
authors.lastname: de Koning
authors.forename: Frans W
authors.initials: FW
authors.lastname: Verheijen
authors.forename: Berthil H
authors.initials: BH
authors.lastname: Prinsen
authors.forename: Frits A
authors.initials: FA
authors.lastname: Wijburg
authors.forename: Ans T
authors.initials: AT
authors.lastname: van der Ploeg
authors.forename: Monique G M
authors.initials: MG
authors.lastname: de Sain-van der Velden
authors.forename: Jaapjan
authors.initials: J
authors.lastname: Boelens
mesh_terms: D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D001774:Blood Chemical Analysis / Q000379:methods*; D002648:Child; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007068:Iduronidase / Q000097:blood; D007962:Leukocytes; D008297:Male; D008722:Methods; D008875:Middle Aged; D025202:Molecular Diagnostic Techniques; D008059:Mucopolysaccharidosis I / Q000175:diagnosis* / Q000628:therapy; D011379:Prognosis; D016896:Treatment Outcome; D055815:Young Adult
chemical_list: D007068:Iduronidase